{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:47:33Z","timestamp":1791100053809,"version":"4.1.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:00:00Z","timestamp":1402963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s10067-014-2722-z","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T07:49:41Z","timestamp":1403164181000},"page":"1197-1207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Key facts and hot spots on tumor necrosis factor receptor\u2010associated periodic syndrome"],"prefix":"10.1007","volume":"33","author":[{"given":"Donato","family":"Rigante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orso Maria","family":"Lucherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"De Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Galeazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,17]]},"reference":[{"key":"2722_CR1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.berh.2008.08.009","volume":"22","author":"I Touitou","year":"2008","unstructured":"Touitou I, Kon\u00e9-Paut I (2008) Autoinflammatory diseases. Best Pract Res Clin Rheumatol 22:811\u2013829","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2722_CR2","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott MF (2006) A proposed classification of the immunological diseases. PLoS Med 3:e297","journal-title":"PLoS Med"},{"key":"2722_CR3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJMcibr063500","volume":"355","author":"JP Drenth","year":"2006","unstructured":"Drenth JP, van der Meer JW (2006) The inflammasome\u2014a linebacker of innate defense. N Engl J Med 355:730\u2013732","journal-title":"N Engl J Med"},{"key":"2722_CR4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.autrev.2011.10.008","volume":"11","author":"D Rigante","year":"2012","unstructured":"Rigante D (2012) The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev 11:348\u2013356","journal-title":"Autoimmun Rev"},{"issue":"Suppl 1","key":"2722_CR5","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1007\/s10875-008-9178-3","volume":"28","author":"M Gattorno","year":"2008","unstructured":"Gattorno M, Federici S, Pelagatti MA, Caorsi R, Brisca G, Malattia C et al (2008) Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol 28(Suppl 1):S73\u2013S83","journal-title":"J Clin Immunol"},{"key":"2722_CR6","first-page":"RA179","volume":"15","author":"D Rigante","year":"2009","unstructured":"Rigante D (2009) Autoinflammatory syndromes behind the scenes of recurrent fevers in children. Med Sci Monit 15:RA179\u2013RA187","journal-title":"Med Sci Monit"},{"key":"2722_CR7","first-page":"469","volume":"51","author":"LM Williamson","year":"1982","unstructured":"Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ (1982) Familial Hibernian fever. Q J Med 51:469\u2013480","journal-title":"Q J Med"},{"key":"2722_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M et al (1999) Germline mutations in the extracellular domains of the 55\u00a0kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133\u2013144","journal-title":"Cell"},{"key":"2722_CR9","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/art.11215","volume":"48","author":"E Aganna","year":"2003","unstructured":"Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HK et al (2003) Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum 48:2632\u20132644","journal-title":"Arthritis Rheum"},{"key":"2722_CR10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/321976","volume":"69","author":"I Aksentijevich","year":"2001","unstructured":"Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH et al (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301\u2013314","journal-title":"Am J Hum Genet"},{"key":"2722_CR11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000314981","volume":"80","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Lucherini OM, Cimaz R, Brizi MG, Galeazzi M (2010) Serosal involvement in adult-onset autoinflammatory disorders. Respiration 80:260\u2013261","journal-title":"Respiration"},{"key":"2722_CR12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00392-012-0422-8","volume":"101","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Lucherini OM, Brucato A, Barone L, Cumetti D, Iacoponi F et al (2012) Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol 101:525\u2013531","journal-title":"Clin Res Cardiol"},{"key":"2722_CR13","first-page":"405","volume":"28","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Lucherini OM, Baldari CT, Laghi Pasini F, Galeazzi M (2010) Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol 28:405\u2013407","journal-title":"Clin Exp Rheumatol"},{"key":"2722_CR14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/039463200902200421","volume":"22","author":"L Cantarini","year":"2009","unstructured":"Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S et al (2009) Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol 22:1051\u20131058","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2722_CR15","first-page":"290","volume":"28","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Laghi Pasini F, Galeazzi M (2010) Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy. Clin Exp Rheumatol 28:290\u2013291","journal-title":"Clin Exp Rheumatol"},{"key":"2722_CR16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/rheumatology\/kep140","volume":"48","author":"E Lainka","year":"2009","unstructured":"Lainka E, Neudorf U, Lohse P, Timmann C, Stojanov S, Huss K et al (2009) Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics. Rheumatology (Oxford) 48:987\u2013991","journal-title":"Rheumatology (Oxford)"},{"key":"2722_CR17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","volume":"81","author":"KM Hull","year":"2002","unstructured":"Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM et al (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349\u2013368","journal-title":"Medicine (Baltimore)"},{"key":"2722_CR18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00431-003-1338-0","volume":"163","author":"K Kusuhara","year":"2004","unstructured":"Kusuhara K, Nomura A, Nakao F, Hara T (2004) Tumour necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family. Eur J Pediatr 163:30\u201332","journal-title":"Eur J Pediatr"},{"key":"2722_CR19","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1086\/301886","volume":"62","author":"MF McDermott","year":"1998","unstructured":"McDermott MF, Ogunkolade BW, McDermott EM, Jones LC, Wan Y, Quane KA et al (1998) Linkage of familial Hibernian fever to chromosome 12p13. Am J Hum Genet 62:1446\u20131451","journal-title":"Am J Hum Genet"},{"key":"2722_CR20","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1086\/301793","volume":"62","author":"J Mulley","year":"1998","unstructured":"Mulley J, Saar K, Hewitt G, Ruschendorf F, Phillips H, Colley A et al (1998) Gene localization for an autosomal dominant familial periodic fever to 12p13. Am J Hum Genet 62:884\u2013889","journal-title":"Am J Hum Genet"},{"key":"2722_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BSR20110089","volume":"32","author":"MD Turner","year":"2012","unstructured":"Turner MD, Chaudhry A, Nedjai B (2012) Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion. Biosci Rep 32:105\u2013112","journal-title":"Biosci Rep"},{"key":"2722_CR22","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/art.21964","volume":"54","author":"SL Rebelo","year":"2006","unstructured":"Rebelo SL, Bainbridge SE, Amel-Kashipaz MR, Radford PM, Powell RJ, Todd I et al (2006) Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum 54:2674\u20132687","journal-title":"Arthritis Rheum"},{"key":"2722_CR23","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Rigante D, Merlini G, Vitale A, Caso F, Lucherini OM et al (2013) The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. Semin Arthritis Rheum. doi: 10.1016\/j.semarthrit.2013.12.002","journal-title":"Semin Arthritis Rheum"},{"key":"2722_CR24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/nar\/gkg031","volume":"31","author":"C Sarrauste de Menthiere","year":"2003","unstructured":"Sarrauste de Menthiere C, Terriere S, Pugnere D, Ruiz M, Demaille J, Touitou I (2003) INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res 31:282\u2013285","journal-title":"Nucleic Acids Res"},{"key":"2722_CR25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.molmed.2011.05.006","volume":"17","author":"AA Lobito","year":"2011","unstructured":"Lobito AA, Gabriel TL, Medema JP, Kimberley FC (2011) Disease causing mutations in the TNF and TNFR superfamilies: focus on molecular mechanisms driving disease. Trends Mol Med 17:494\u2013505","journal-title":"Trends Mol Med"},{"key":"2722_CR26","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","volume":"334","author":"F Bazzoni","year":"1996","unstructured":"Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717\u20131725","journal-title":"N Engl J Med"},{"key":"2722_CR27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nri1151","volume":"3","author":"JL Gommerman","year":"2003","unstructured":"Gommerman JL, Browning JL (2003) Lymphotoxin\/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 3:642\u2013655","journal-title":"Nat Rev Immunol"},{"key":"2722_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.0906-6705.2004.00205.x","volume":"13","author":"AJ Schottelius","year":"2004","unstructured":"Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards CK 3rd (2004) Biology of tumor necrosis factor-alpha\u2014implications for psoriasis. Exp Dermatol 13:193\u2013222","journal-title":"Exp Dermatol"},{"key":"2722_CR29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semarthrit.2005.01.002","volume":"34","author":"G Kollias","year":"2005","unstructured":"Kollias G (2005) TNF pathophysiology in murine models of chronic inflammation and autoimmunity. Semin Arthritis Rheum 34:3\u20136","journal-title":"Semin Arthritis Rheum"},{"key":"2722_CR30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","volume":"6","author":"F Aloisi","year":"2006","unstructured":"Aloisi F, Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6:205\u2013217","journal-title":"Nat Rev Immunol"},{"key":"2722_CR31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/oxfordjournals.bmb.a072967","volume":"51","author":"FM Brennan","year":"1995","unstructured":"Brennan FM, Maini RN, Feldmann M (1995) Cytokine expression in chronic inflammatory disease. Br Med Bull 51:368\u2013384","journal-title":"Br Med Bull"},{"key":"2722_CR32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.iy.07.040189.003205","volume":"7","author":"B Beutler","year":"1989","unstructured":"Beutler B, Cerami A (1989) The biology of cachectin\/TNF\u2014a primary mediator of the host response. Annu Rev Immunol 7:625\u2013655","journal-title":"Annu Rev Immunol"},{"key":"2722_CR33","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.149.12.3881","volume":"149","author":"CF Ware","year":"1992","unstructured":"Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL (1992) Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J Immunol 149:3881\u20133888","journal-title":"J Immunol"},{"key":"2722_CR34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","volume":"10","author":"P Vassalli","year":"1992","unstructured":"Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411\u2013452","journal-title":"Annu Rev Immunol"},{"key":"2722_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","volume":"10","author":"H Wajant","year":"2003","unstructured":"Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10:45\u201365","journal-title":"Cell Death Differ"},{"key":"2722_CR36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar2197","volume":"9","author":"FC Kimberley","year":"2007","unstructured":"Kimberley FC, Lobito AA, Siegel RM, Screaton GR (2007) Falling into TRAPS\u2014receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther 9:217","journal-title":"Arthritis Res Ther"},{"key":"2722_CR37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-A","volume":"73","author":"DW Banner","year":"1993","unstructured":"Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C et al (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73:431\u2013445","journal-title":"Cell"},{"key":"2722_CR38","first-page":"141","volume":"31","author":"F Magnotti","year":"2013","unstructured":"Magnotti F, Vitale A, Rigante D, Lucherini OM, Cimaz R, Muscari I et al (2013) The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review. Clin Exp Rheumatol 31:141\u2013149","journal-title":"Clin Exp Rheumatol"},{"key":"2722_CR39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2005-11-006783","volume":"108","author":"AA Lobito","year":"2006","unstructured":"Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM et al (2006) Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108:1320\u20131327","journal-title":"Blood"},{"key":"2722_CR40","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/art.20380","volume":"50","author":"ML Huggins","year":"2004","unstructured":"Huggins ML, Radford PM, McIntosh RS, Bainbridge SE, Dickinson P, Draper-Morgan KA et al (2004) Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis Rheum 50:2651\u20132659","journal-title":"Arthritis Rheum"},{"key":"2722_CR41","first-page":"2519","volume":"31","author":"T Kallinich","year":"2004","unstructured":"Kallinich T, Briese S, Roesler J, Rudolph B, Sarioglu N, Blankenstein O et al (2004) Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis. J Rheumatol 31:2519\u20132522","journal-title":"J Rheumatol"},{"key":"2722_CR42","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2007.079376","volume":"67","author":"S Stojanov","year":"2008","unstructured":"Stojanov S, Dejaco C, Lohse P, Huss K, Duftner C, Belohradsky BH et al (2008) Clinical and functional characterisation of a novel TNFRSF1A c.605\u00a0T\u2009>\u2009A\/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann Rheum Dis 67:1292\u20131298","journal-title":"Ann Rheum Dis"},{"key":"2722_CR43","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nri3261","volume":"12","author":"H Park","year":"2012","unstructured":"Park H, Bourla AB, Kastner DL, Colbert RA, Siegel RM (2012) Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol 12:570\u2013580","journal-title":"Nat Rev Immunol"},{"key":"2722_CR44","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1073\/pnas.0914118107","volume":"107","author":"A Simon","year":"2010","unstructured":"Simon A, Park H, Maddipati R, Lobito AA, Bulua AC, Jackson AJ et al (2010) Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. Proc Natl Acad Sci U S A 107:9801\u20139806","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2722_CR45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20102049","volume":"208","author":"AC Bulua","year":"2011","unstructured":"Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY et al (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 208:519\u2013533","journal-title":"J Exp Med"},{"key":"2722_CR46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2004.12.041","volume":"120","author":"H Kamata","year":"2005","unstructured":"Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M (2005) Reactive oxygen species promote TNF alpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649\u2013661","journal-title":"Cell"},{"key":"2722_CR47","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/annrheumdis-2011-201197","volume":"71","author":"LJ Dickie","year":"2012","unstructured":"Dickie LJ, Aziz AM, Savic S, Lucherini OM, Cantarini L, Geiler J et al (2012) Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome. Ann Rheum Dis 71:2035\u20132043","journal-title":"Ann Rheum Dis"},{"key":"2722_CR48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0968-0004(96)10073-6","volume":"22","author":"HL Pahl","year":"1997","unstructured":"Pahl HL, Baeuerle PA (1997) The ER-overload response: activation of NF-kappa B. Trends Biochem Sci 22:63\u201367","journal-title":"Trends Biochem Sci"},{"key":"2722_CR49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.cellbio.21.122303.120200","volume":"22","author":"S Bernales","year":"2006","unstructured":"Bernales S, Papa FR, Walter P (2006) Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol 22:487\u2013508","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2722_CR50","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/annrheumdis-2012-201952","volume":"72","author":"T Bachetti","year":"2013","unstructured":"Bachetti T, Chiesa S, Castagnola P, Bani D, Di Zanni E, Omenetti A et al (2013) Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS). Ann Rheum Dis 72:1044\u20131052","journal-title":"Ann Rheum Dis"},{"key":"2722_CR51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar3377","volume":"13","author":"A Ceribelli","year":"2011","unstructured":"Ceribelli A, Yao B, Dominguez-Gutierrez PR, Nahid MA, Satoh M, Chan EK (2011) MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther 13:229","journal-title":"Arthritis Res Ther"},{"key":"2722_CR52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/eurheartj\/ehq013","volume":"31","author":"GK Wang","year":"2010","unstructured":"Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J et al (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31:659\u2013666","journal-title":"Eur Heart J"},{"issue":"8","key":"2722_CR53","doi-asserted-by":"crossref","first-page":"e73443","DOI":"10.1371\/journal.pone.0073443","volume":"16","author":"OM Lucherini","year":"2013","unstructured":"Lucherini OM, Obici L, Ferracin M, Fulci V, McDermott MF, Merlini G et al (2013) First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One 8:e73443","journal-title":"PLoS One"},{"key":"2722_CR54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/annrheumdis-2012-203023","volume":"73","author":"C Rittore","year":"2014","unstructured":"Rittore C, Sanchez E, Soler S, Barat-Houari M, Albers M, Obici L et al (2014) Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene. Ann Rheum Dis 73:290\u2013297","journal-title":"Ann Rheum Dis"},{"key":"2722_CR55","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/039463201002300417","volume":"23","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Lucherini OM, Iacoponi F, Cimaz R, Simonini G, Rigante D et al (2010) Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders. Int J Immunopathol Pharmacol 23:1133\u20131141","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2722_CR56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4081\/reumatismo.2013.55","volume":"65","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Vitale A, Lucherini OM, Muscari I, Magnotti F, Brizi G et al (2013) Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined. Reumatismo 65:55\u201362","journal-title":"Reumatismo"},{"key":"2722_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405009749","volume":"7","author":"S Stojanov","year":"2005","unstructured":"Stojanov S, McDermott MF (2005) The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med 7:1\u201318","journal-title":"Expert Rev Mol Med"},{"key":"2722_CR58","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.10429","volume":"46","author":"C Dod\u00e9","year":"2002","unstructured":"Dod\u00e9 C, Andre M, Bienvenu T, Hausfater P, Pecheux C, Bienvenu J et al (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 46:2181\u20132188","journal-title":"Arthritis Rheum"},{"key":"2722_CR59","doi-asserted-by":"crossref","first-page":"485103","DOI":"10.1155\/2013\/485103","volume":"2013","author":"D Rigante","year":"2013","unstructured":"Rigante D, Frediani B, Galeazzi M, Cantarini L (2013) From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases. Biomed Res Int 2013:485103","journal-title":"Biomed Res Int"},{"key":"2722_CR60","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1007\/s00296-010-1512-4","volume":"32","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Lucherini OM, Cimaz R, Rigante D, Baldari CT, Laghi Pasini F et al (2012) Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series. Rheumatol Int 32:4015\u20134018","journal-title":"Rheumatol Int"},{"key":"2722_CR61","author":"HJ Lachmann","year":"2013","unstructured":"Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L et al (2013) The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-204184","journal-title":"Ann Rheum Dis"},{"key":"2722_CR62","first-page":"802","volume":"28","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Lucherini OM, Cimaz R, Galeazzi M (2010) Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. Clin Exp Rheumatol 28:802","journal-title":"Clin Exp Rheumatol"},{"key":"2722_CR63","first-page":"1487","volume":"136","author":"JR Toro","year":"2000","unstructured":"Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL (2000) Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 136:1487\u20131494","journal-title":"Arch Dermatol"},{"key":"2722_CR64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00403-011-1134-z","volume":"303","author":"D Rigante","year":"2011","unstructured":"Rigante D, Cantarini L (2011) Monogenic autoinflammatory syndromes at a dermatological level. Arch Dermatol Res 303:375\u2013380","journal-title":"Arch Dermatol Res"},{"key":"2722_CR65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/derm.2.1.12387","volume":"2","author":"R Schmaltz","year":"2010","unstructured":"Schmaltz R, Vogt T, Reichrath J (2010) Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Dermatoendocrinol 2:26\u201329","journal-title":"Dermatoendocrinol"},{"key":"2722_CR66","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/art.10448","volume":"46","author":"KM Hull","year":"2002","unstructured":"Hull KM, Wong K, Wood GM, Chu WS, Kastner DL (2002) Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction. Arthritis Rheum 46:2189\u20132194","journal-title":"Arthritis Rheum"},{"key":"2722_CR67","author":"F Caso","year":"2013","unstructured":"Caso F, Rigante D, Vitale A, Lucherini OM, Costa L, Atteno M et al (2013) Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol. doi: 10.1155\/2013\/513782","journal-title":"Int J Rheumatol"},{"key":"2722_CR68","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.gastro.2005.09.014","volume":"130","author":"SL Haas","year":"2006","unstructured":"Haas SL, Lohse P, Schmitt WH, Hildenbrand R, Karaorman M, Singer MV et al (2006) Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution. Gastroenterology 130:172\u2013178","journal-title":"Gastroenterology"},{"key":"2722_CR69","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.semarthrit.2011.07.008","volume":"41","author":"Q Yao","year":"2012","unstructured":"Yao Q, Englund KA, Hayden SP, Tomecki KJ (2012) Tumor necrosis factor receptor associated periodic fever syndrome with photographic evidence of various skin disease and unusual phenotypes: case report and literature review. Semin Arthritis Rheum 41:611\u2013617","journal-title":"Semin Arthritis Rheum"},{"key":"2722_CR70","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/ard.2003.016006","volume":"63","author":"K Minden","year":"2004","unstructured":"Minden K, Aganna E, McDermott MF, Zink A (2004) Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement. Ann Rheum Dis 63:1356\u20131357","journal-title":"Ann Rheum Dis"},{"key":"2722_CR71","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1212\/01.wnl.0000260226.21010.2b","volume":"68","author":"B Wildemann","year":"2007","unstructured":"Wildemann B, Rudofsky G Jr, Kress B, Jarius S, Konig F, Schwenger V (2007) The tumor-necrosis-factor-associated periodic syndrome, the brain, and tumor-necrosis-factor-alpha antagonists. Neurology 68:1742\u20131744","journal-title":"Neurology"},{"key":"2722_CR72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.autrev.2012.07.016","volume":"12","author":"L Obici","year":"2012","unstructured":"Obici L, Merlini G (2012) Amyloidosis in autoinflammatory syndromes. Autoimmun Rev 12:14\u201317","journal-title":"Autoimmun Rev"},{"key":"2722_CR73","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1515\/CCLM.2011.127","volume":"49","author":"D Rigante","year":"2011","unstructured":"Rigante D, Capoluongo E (2011) The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation. Clin Chem Lab Med 49:783\u2013791","journal-title":"Clin Chem Lab Med"},{"key":"2722_CR74","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/art.30237","volume":"63","author":"MA Pelagatti","year":"2011","unstructured":"Pelagatti MA, Meini A, Caorsi R, Cattalini M, Federici S, Zulian F et al (2011) Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheum 63:1141\u20131150","journal-title":"Arthritis Rheum"},{"key":"2722_CR75","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/ard.2005.048611","volume":"65","author":"N Ravet","year":"2006","unstructured":"Ravet N, Rouaghe S, Dode C, Bienvenu J, Stirnemann J, Levy P et al (2006) Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis 65:1158\u20131162","journal-title":"Ann Rheum Dis"},{"key":"2722_CR76","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00296-010-1530-2","volume":"31","author":"L Cantarini","year":"2011","unstructured":"Cantarini L, Lucherini OM, Cimaz R, Brizi MG, Galeazzi M (2011) Autoinflammatory disorders and patients with isolated serosal involvement. Rheumatol Int 31:979\u2013980","journal-title":"Rheumatol Int"},{"key":"2722_CR77","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12016-010-8219-x","volume":"44","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Imazio M, Brizi MG, Lucherini OM, Brucato A, Cimaz R et al (2013) Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol 44:6\u201313","journal-title":"Clin Rev Allergy Immunol"},{"key":"2722_CR78","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/imj.12163","volume":"43","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Lucherini OM, Vitale A, Sabadini L, Brizi MG, Frediani B et al (2013) Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis. Intern Med J 43:725\u2013727","journal-title":"Intern Med J"},{"key":"2722_CR79","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.autrev.2009.11.021","volume":"9","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Imazio M, Brucato A, Lucherini OM, Galeazzi M (2010) Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis. Autoimmun Rev 9:436\u2013440","journal-title":"Autoimmun Rev"},{"key":"2722_CR80","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/07853890.2010.547212","volume":"43","author":"D Rigante","year":"2011","unstructured":"Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M et al (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341\u2013346","journal-title":"Ann Med"},{"key":"2722_CR81","first-page":"175","volume":"32","author":"S Trost","year":"2005","unstructured":"Trost S, Rose CD (2005) Myocarditis and sacroiliitis: 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. J Rheumatol 32:175\u2013177","journal-title":"J Rheumatol"},{"key":"2722_CR82","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ejim.2008.07.028","volume":"20","author":"F Roubille","year":"2009","unstructured":"Roubille F, Cayla G, Gahide G, Mourad G, Macia JC (2009) Acute myocarditis and tumor necrosis factor receptor-associated periodic (TRAP) syndrome: first case described and discussion. Eur J Intern Med 20:e25\u2013e26","journal-title":"Eur J Intern Med"},{"key":"2722_CR83","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.ATV.0000065195.22904.FA","volume":"23","author":"S Chia","year":"2003","unstructured":"Chia S, Qadan M, Newton R, Ludlam CA, Fox KA, Newby DE (2003) Intra-arterial tumor necrosis factor-alpha impairs endotheliumdependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol 23:695\u2013701","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2722_CR84","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2012.07.015","volume":"12","author":"I Muscari","year":"2012","unstructured":"Muscari I, Iacoponi F, Cantarini L, Lucherini OM, Simonini G, Brizi MG et al (2012) The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Autoimmun Rev 12:10\u201313","journal-title":"Autoimmun Rev"},{"key":"2722_CR85","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/039463201102400315","volume":"24","author":"L Cantarini","year":"2011","unstructured":"Cantarini L, Iacoponi F, Lucherini OM, Obici L, Brizi MG, Cimaz R et al (2011) Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. Int J Immunopathol Pharmacol 24:695\u2013702","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2722_CR86","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2010.02.014","volume":"50","author":"G Manukyan","year":"2010","unstructured":"Manukyan G, Ghazaryan K, Ktsoyan Z, Khachatryan Z, Kelly D, Tatyan M et al (2010) Comparative analysis of cytokine profiles in autoinflammatory and autoimmune conditions. Cytokine 50:146\u2013151","journal-title":"Cytokine"},{"key":"2722_CR87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4613-0733-4_23","volume":"243","author":"G Husby","year":"1988","unstructured":"Husby G, Husebekk A, Skogen B, Sletten K, Marhaug G, Magnus J et al (1988) Serum amyloid A (SAA)-the precursor of protein AA in secondary amyloidosis. Adv Exp Med Biol 243:185\u2013192","journal-title":"Adv Exp Med Biol"},{"key":"2722_CR88","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1189\/jlb.69.6.986","volume":"69","author":"Z Yang","year":"2001","unstructured":"Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL (2001) Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 69:986\u2013994","journal-title":"J Leukoc Biol"},{"key":"2722_CR89","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/07853890.2011.598546","volume":"44","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Rigante D, Brizi MG, Lucherini OM, Sebastiani GD, Vitale A et al (2012) Clinical and biochemical landmarks in systemic autoinflammatory diseases. Ann Med 44:664\u2013673","journal-title":"Ann Med"},{"key":"2722_CR90","first-page":"S108","volume":"30","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Obici L, Simonini G, Cimaz R, Bacarelli MR, Merlini G et al (2012) Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Clin Exp Rheumatol 30:S108\u2013S114","journal-title":"Clin Exp Rheumatol"},{"key":"2722_CR91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autrev.2012.07.020","volume":"12","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG et al (2012) Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Autoimmun Rev 12:38\u201343","journal-title":"Autoimmun Rev"},{"key":"2722_CR92","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","volume":"72","author":"N Haar Ter","year":"2013","unstructured":"Ter Haar N, Lachmann H, Ozen S, Woo P, Uziel Y, Modesto C et al (2013) Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 72:678\u2013685","journal-title":"Ann Rheum Dis"},{"key":"2722_CR93","first-page":"890","volume":"27","author":"L Cantarini","year":"2009","unstructured":"Cantarini L, Lucherini OM, Galeazzi M, Fanti F, Simonini G, Baldari CT et al (2009) Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment. Clin Exp Rheumatol 27:890\u2013891","journal-title":"Clin Exp Rheumatol"},{"key":"2722_CR94","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/039463201002300303","volume":"23","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Rigante D, Lucherini OM, Cimaz R, Laghi Pasini F, Baldari CT et al (2010) Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature. Int J Immunopathol Pharmacol 23:701\u2013707","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2722_CR95","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.33416","volume":"64","author":"AC Bulua","year":"2012","unstructured":"Bulua AC, Mogul DB, Aksentijevich I, Singh H, He DY, Muenz LR et al (2012) Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study. Arthritis Rheum 64:908\u2013913","journal-title":"Arthritis Rheum"},{"key":"2722_CR96","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/keh357","volume":"43","author":"E Drewe","year":"2004","unstructured":"Drewe E, Huggins ML, Morgan AG, Cassidy MJ, Powell RJ (2004) Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford) 43:1405\u20131408","journal-title":"Rheumatology (Oxford)"},{"key":"2722_CR97","first-page":"119","volume":"23","author":"I Simsek","year":"2010","unstructured":"Simsek I, Kaya A, Erdem H, Pay S, Yenicesu M, Dinc A (2010) No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy. J Nephrol 23:119\u2013123","journal-title":"J Nephrol"},{"key":"2722_CR98","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/art.23475","volume":"58","author":"M Gattorno","year":"2008","unstructured":"Gattorno M, Pelagatti MA, Meini A, Obici L, Barcellona R, Federici S et al (2008) Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 58:1516\u20131520","journal-title":"Arthritis Rheum"},{"key":"2722_CR99","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/rheumatology\/kel298","volume":"46","author":"S Jacobelli","year":"2007","unstructured":"Jacobelli S, Andre M, Alexandra JF, Dode C, Papo T (2007) Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology (Oxford) 46:1211\u20131212","journal-title":"Rheumatology (Oxford)"},{"key":"2722_CR100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.24294","volume":"60","author":"B Nedjai","year":"2009","unstructured":"Nedjai B, Hitman GA, Quillinan N, Coughlan RJ, Church L, McDermott MF et al (2009) Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 60:619\u2013625","journal-title":"Arthritis Rheum"},{"key":"2722_CR101","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/rheumatology\/kem231","volume":"46","author":"E Drewe","year":"2007","unstructured":"Drewe E, Powell RJ, McDermott EM (2007) Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology (Oxford) 46:1865\u20131866","journal-title":"Rheumatology (Oxford)"},{"key":"2722_CR102","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","volume":"301","author":"B Scallon","year":"2002","unstructured":"Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D et al (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301:418\u2013426","journal-title":"J Pharmacol Exp Ther"},{"key":"2722_CR103","doi-asserted-by":"crossref","first-page":"939847","DOI":"10.1155\/2013\/939847","volume":"2013","author":"A Vitale","year":"2013","unstructured":"Vitale A, Rigante D, Lucherini OM, Caso F, Muscari I, Magnotti F et al (2013) Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediat Inflamm 2013:939847","journal-title":"Mediat Inflamm"},{"key":"2722_CR104","first-page":"357","volume":"35","author":"K Sacre","year":"2008","unstructured":"Sacre K, Brihaye B, Lidove O, Papo T, Pocidalo MA, Cuisset L et al (2008) Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy. J Rheumatol 35:357\u2013358","journal-title":"J Rheumatol"},{"key":"2722_CR105","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/ard.2010.143438","volume":"70","author":"L Obici","year":"2011","unstructured":"Obici L, Meini A, Cattalini M, Chicca S, Galliani M, Donadei S et al (2011) Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis. Ann Rheum Dis 70:1511\u20131512","journal-title":"Ann Rheum Dis"},{"key":"2722_CR106","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2010.144279","volume":"70","author":"N Quillinan","year":"2011","unstructured":"Quillinan N, Mannion G, Mohammad A, Coughlan R, Dickie LJ, McDermott MF et al (2011) Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome. Ann Rheum Dis 70:1692\u20131693","journal-title":"Ann Rheum Dis"},{"key":"2722_CR107","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7326\/0003-4819-156-12-201206190-00027","volume":"156","author":"MG Brizi","year":"2012","unstructured":"Brizi MG, Galeazzi M, Lucherini OM, Cantarini L, Cimaz R (2012) Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab. Ann Intern Med 156:907\u2013908","journal-title":"Ann Intern Med"},{"key":"2722_CR108","first-page":"229","volume":"14","author":"U Arad","year":"2012","unstructured":"Arad U, Niv E, Caspi D, Elkayam O (2012) \u201cTRAP\u201d the diagnosis: a man with recurrent episodes of febrile peritonitis, not just familial Mediterranean fever. Isr Med Assoc J 14:229\u2013231","journal-title":"Isr Med Assoc J"},{"key":"2722_CR109","first-page":"749","volume":"64","author":"M Gattorno","year":"2012","unstructured":"Gattorno M, Obici L, Meini A, Tormey V, Abrams K, Davis N et al (2012) Efficacy and safety of canakinumab in patients with TNF receptor associated periodic syndrome [abstract]. Arthritis Rheum 64:749","journal-title":"Arthritis Rheum"},{"key":"2722_CR110","doi-asserted-by":"crossref","unstructured":"Lopalco G, Rigante D, Vitale A, Frediani B, Iannone F, Cantarini L (2014) Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate. Clin Rheumatol Mar 11 - Epub ahead of print","DOI":"10.1007\/s10067-014-2556-8"},{"key":"2722_CR111","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1750-1172-8-196","volume":"8","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Vitale A, Magnotti F, Lucherini OM, Caso F, Frediani B et al (2013) Weekly oral alendronate in mevalonate kinase deficiency. Orphanet J Rare Dis 8:196","journal-title":"Orphanet J Rare Dis"},{"key":"2722_CR112","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/rheumatology\/kei090","volume":"45","author":"ML Nowlan","year":"2006","unstructured":"Nowlan ML, Drewe E, Bulsara H, Esposito N, Robins RA, Tighe PJ et al (2006) Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology (Oxford) 45:31\u201337","journal-title":"Rheumatology (Oxford)"},{"key":"2722_CR113","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.30215","volume":"63","author":"PM Vaitla","year":"2011","unstructured":"Vaitla PM, Radford PM, Tighe PJ, Powell RJ, McDermott EM, Todd I et al (2011) Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab. Arthritis Rheum 63:1151\u20131155","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2722-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2722-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2722-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T11:30:08Z","timestamp":1689334208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2722-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,17]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2722"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2722-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,17]]}}}